Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism β3-adrenergic receptor agonists(Beta-3 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H19F3N2O4S |
InChIKeyYVIXXPCJZAUQHJ-YGRLFVJLSA-N |
CAS Registry162326-86-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Phase 1 | US | - |